Aptose Biosciences Stock Price and Value Analysis

Should you buy Aptose Biosciences stock? (NasdaqCM:APTO). Let's see how it does in our automated value investing analysis system.

APTO Free Cash Flow Trend

Free Cash Flow trendline for APTO
Free Cash Flow trendline for Aptose Biosciences

Hmm, we can't give any reliable projection for Aptose Biosciences's growth rate. The company either has too few years of historical data for us to examine, or it's in the habit of losing money.

None of this means it's a bad stock. Maybe it's new and growing quickly, or maybe it's turning things around. We can't say anything sensible about it, so we won't say it's obviously undervalued right now. Proceed at your own risk!

  • This company has amazingly consistent growth!
  • This company is not making money.
  • This stock looks overpriced.
  • This company is less known than others.
  • This company pays no dividend.

Inside the APTO Numbers

APTO Price
(Aptose Biosciences stock price per share)
[?] PE Ratio versus Sector 100% lower than other Healthcare stocks
[?] PE Ratio versus Industry 100% lower than other Biotechnology stocks

Is Aptose Biosciences Stock on Sale?

Based on our analysis, we believe that you should not buy Aptose Biosciences right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy APTO Stock?

Does Aptose Biosciences have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.